Profitability and improved patient care--industry's viewpoint.
作者信息
Snell E S
出版信息
Br J Clin Pharmacol. 1986;22 Suppl 1(Suppl 1):33S-39S. doi: 10.1111/j.1365-2125.1986.tb02979.x.
Abstract
摘要
相似文献
1
Profitability and improved patient care--industry's viewpoint.盈利能力与改善患者护理——行业观点
Br J Clin Pharmacol. 1986;22 Suppl 1(Suppl 1):33S-39S. doi: 10.1111/j.1365-2125.1986.tb02979.x.
2
Profitability and improved patient care--the physician's viewpoint.盈利能力与改善患者护理——医生的观点。
Br J Clin Pharmacol. 1986;22 Suppl 1(Suppl 1):41S-43S. doi: 10.1111/j.1365-2125.1986.tb02980.x.
3
The demise of Bayh-Dole protections against the Pharmaceutical Industry's abuses of government-funded inventions.拜杜法案针对制药行业滥用政府资助发明行为的保护措施的终结。
J Law Med Ethics. 2004 Winter;32(4):777-83. doi: 10.1111/j.1748-720x.2004.tb01985.x.
4
[Drug industry's misuse of patents must be prevented].必须防止制药行业滥用专利。
Lakartidningen. 2008;105(8):555.
5
Redesigner drugs.新型毒品
Nat Biotechnol. 2004 Aug;22(8):953-7. doi: 10.1038/nbt0804-953.
6
Drug companies and third world: a case study in neglect. Medicine merchants: a special report.
N Y Times Web. 2000 May 21:A1,6.
7
[Biopharmaceutical industry's commitment to innovation and to the future of health care].生物制药行业对创新及医疗保健未来的承诺
Recenti Prog Med. 2006 Nov;97(11):626-33.
8
It is not unethical, though it is often unwise, to override patents.
Am J Bioeth. 2002 Summer;2(3):50-1. doi: 10.1162/152651602760250165.
9
Patents: a threat to innovation?专利：对创新的威胁？
Science. 2010 Jan 1;327(5961):31-2; author reply 32. doi: 10.1126/science.327.5961.31.
10
How companies stall generics and keep themselves healthy.
N Y Times Web. 2000 Jul 23:A1, A14, A15.
本文引用的文献
1
Drug promotion and the doctor--a reply.药物推广与医生——答复
Br J Clin Pharmacol. 1982 Nov;14(5):664-6. doi: 10.1111/j.1365-2125.1982.tb04953.x.
2
Drug promotion and the doctor.药品促销与医生
Br J Clin Pharmacol. 1982 Nov;14(5):661-4. doi: 10.1111/j.1365-2125.1982.tb04952.x.
3
Survey of patient information booklets.患者信息手册调查
Br Med J (Clin Res Ed). 1984 Mar 24;288(6421):915-9. doi: 10.1136/bmj.288.6421.915.
4
Doctors and the drug makers.医生与制药商。
Lancet. 1984 Aug 4;2(8397):276-8. doi: 10.1016/s0140-6736(84)90313-1.
5
Drug research and development in the pharmaceutical industry.制药行业的药物研发
Br J Clin Pharmacol. 1986;22 Suppl 1(Suppl 1):9S-14S. doi: 10.1111/j.1365-2125.1986.tb02975.x.
6
The economics of drug development and use.药物研发与使用的经济学
Br J Clin Pharmacol. 1986;22 Suppl 1(Suppl 1):45S-48S. doi: 10.1111/j.1365-2125.1986.tb02981.x.
Zotero 插件